Señales en vivo de CMPI | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 dic 1970 @ 19:00):

Checkmate Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing novel therapeutics for the treatment of cancer...

Stats
Volumen de hoy	63 651.00
Volumen promedio	233 019
Capitalización de mercado	0.00
EPS	$-0.730 ( 2022-05-12 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.85
ATR14	$0.291 (2.77%)

Insider Trading

Date	Person	Action	Amount	type
2022-05-31	Powell Michael	Sell	30 000	Stock Option (Right to Buy)
2022-05-31	Powell Michael	Sell	10 030	Stock Option (Right to Buy)
2022-05-31	Powell Michael	Sell	30 000	Stock Option (Right to Buy)
2022-05-31	Flaherty Keith T.	Sell	10 030	Stock Option (Right to Buy)
2022-05-31	Flaherty Keith T.	Sell	4 012	Stock Option (Right to Buy)

INSIDER POWER
-100.00
Last 90 transactions
Buy: 10 162 192 \| Sell: 69 692 426

Volumen Correlación

Largo: 0.41 (neutral)

Corto: -0.45 (neutral)

Signal:(88.816) Neutral

Checkmate Correlación

10 Correlaciones Más Positivas
WPRT	0.988
RETA	0.975
ORTX	0.973
RESN	0.969
RXDX	0.969
ACOR	0.965
ZGNX	0.965
GNLN	0.961
PBPB	0.961
ADMS	0.96

10 Correlaciones Más Negativas
EYE	-0.966
IEP	-0.958
PEBK	-0.956
PINC	-0.955
AADI	-0.951
CPTN	-0.949
MDRX	-0.949
LCUT	-0.945
PSHG	-0.944
TTEC	-0.944

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Checkmate Correlación - Moneda/Commodity

0.74
( moderate )

0.02
( neutral )

0.36
( neutral )

0.50
( neutral )

-0.72
( moderate negative )

Checkmate Finanzas

Annual	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-6.42

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-6.42

FY	2020
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-4.49

FY	2019
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-3.44

Financial Reports:

No articles found.

Checkmate

Checkmate Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing novel therapeutics for the treatment of cancer. It develops CMP-001, which is in phase II clinical trial in combination with pembrolizumab to treat patients with PD-1 refractory melanoma; combination with nivolumab to treat patients with PD-1 naïve neoadjuvant melanoma; and treatment in patients with PD-1 refractory melanoma. Checkmate Pharmaceuticals, Inc. has strategic alliances with Merck KGaA and Pfizer. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. As of May 27, 2022, Checkmate Pharmaceuticals, Inc. operates as a subsidiary of Regeneron Pharmaceuticals, Inc.